Loading...
Capacity Expansions And Advanced Modalities Will Capture Global Pharma Demand
AnalystHighTarget's Fair Value
CHF 136.00
40.2% undervalued intrinsic discount26 Jun
CHF 81.30
1Y
-28.8%7D
3.3%1Y
-28.8%7D
3.3%You can edit this narrative until Jun 26 9:15 PM. Then, changes will post as Updates.